AR049028A1 - Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion - Google Patents
Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacionInfo
- Publication number
- AR049028A1 AR049028A1 ARP050101549A ARP050101549A AR049028A1 AR 049028 A1 AR049028 A1 AR 049028A1 AR P050101549 A ARP050101549 A AR P050101549A AR P050101549 A ARP050101549 A AR P050101549A AR 049028 A1 AR049028 A1 AR 049028A1
- Authority
- AR
- Argentina
- Prior art keywords
- mirtazapine
- enantiomer
- manufacturing
- sublimate
- solid salt
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 2
- 229960001785 mirtazapine Drugs 0.000 title 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical class NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 abstract 1
- RONZAEMNMFQXRA-INIZCTEOSA-N LSM-5894 Chemical class C1C2=CC=CN=C2N2CCN(C)C[C@H]2C2=CC=CC=C21 RONZAEMNMFQXRA-INIZCTEOSA-N 0.000 abstract 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
- 239000001530 fumaric acid Chemical class 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 239000011976 maleic acid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Una composicion y métodos de fabricacion de una sal solida farmacéuticamente adecuada y que no sublima de un enantiomero de mirtazapina, en particular, una sal de mirtazapina seleccionada de la lista de las sales de ácido maleico, de ácido bromhídrico y de ácido fumárico, para el uso en la fabricacion de una composicion farmacéutica que comprende una sal de S- o R- mirtazapina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101664 | 2004-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049028A1 true AR049028A1 (es) | 2006-06-21 |
Family
ID=34928990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050101549A AR049028A1 (es) | 2004-04-21 | 2005-04-20 | Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion |
Country Status (31)
Country | Link |
---|---|
US (1) | US20070111993A1 (es) |
EP (1) | EP1729777B1 (es) |
JP (2) | JP5260959B2 (es) |
CN (2) | CN101824035A (es) |
AR (1) | AR049028A1 (es) |
AT (1) | ATE424210T1 (es) |
AU (1) | AU2005235383B2 (es) |
BR (1) | BRPI0509953A (es) |
CA (1) | CA2561281C (es) |
CY (1) | CY1109018T1 (es) |
DE (1) | DE602005013066D1 (es) |
DK (1) | DK1729777T3 (es) |
EC (1) | ECSP066938A (es) |
ES (1) | ES2321961T3 (es) |
HR (1) | HRP20090190T1 (es) |
IL (1) | IL178201A (es) |
LV (1) | LV13556B (es) |
MX (1) | MXPA06011830A (es) |
MY (1) | MY144899A (es) |
NO (1) | NO20065077L (es) |
NZ (1) | NZ550052A (es) |
PE (1) | PE20060400A1 (es) |
PL (1) | PL1729777T3 (es) |
PT (1) | PT1729777E (es) |
RS (1) | RS50764B (es) |
RU (1) | RU2375362C2 (es) |
SI (1) | SI1729777T1 (es) |
TW (1) | TW200538100A (es) |
UA (1) | UA89773C2 (es) |
WO (1) | WO2005102352A1 (es) |
ZA (1) | ZA200608305B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
CN104095824B (zh) * | 2013-04-09 | 2016-08-31 | 上海信谊万象药业股份有限公司 | 一种米氮平缓释片及其制备方法 |
CA3013771C (en) | 2015-02-27 | 2024-01-02 | Kindred Biosciences, Inc. | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
US4193828A (en) * | 1976-07-27 | 1980-03-18 | Fiber Materials, Inc. | Method of forming carbon composites |
US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
EP0813873B1 (en) * | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
DK1067934T3 (da) * | 1998-04-02 | 2004-03-29 | Akzo Nobel Nv | Flydende oral opløsning omfattende det anti-depressive middel mirtazapin |
WO2001000196A2 (en) * | 1999-06-25 | 2001-01-04 | University Of South Florida | Mirtazapine for weight gain in wasting diseases |
US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
WO2001042239A1 (fr) * | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Procede de preparation d'un compose pyridinemethanol |
CN1537006A (zh) * | 2000-04-05 | 2004-10-13 | ��˹��ŵ�� | 含有米尔塔扎平和对乙酰氨基酚或一种非甾类消炎药的用于治疗头痛的联合用药物 |
-
2005
- 2005-04-12 TW TW094111559A patent/TW200538100A/zh unknown
- 2005-04-19 MY MYPI20051731A patent/MY144899A/en unknown
- 2005-04-19 CA CA2561281A patent/CA2561281C/en not_active Expired - Fee Related
- 2005-04-19 ES ES05740221T patent/ES2321961T3/es active Active
- 2005-04-19 JP JP2007508904A patent/JP5260959B2/ja not_active Expired - Fee Related
- 2005-04-19 NZ NZ550052A patent/NZ550052A/en unknown
- 2005-04-19 US US11/547,152 patent/US20070111993A1/en not_active Abandoned
- 2005-04-19 PT PT05740221T patent/PT1729777E/pt unknown
- 2005-04-19 AU AU2005235383A patent/AU2005235383B2/en active Active
- 2005-04-19 UA UAA200610312A patent/UA89773C2/ru unknown
- 2005-04-19 RU RU2006140988/04A patent/RU2375362C2/ru not_active IP Right Cessation
- 2005-04-19 RS RSP-2009/0164A patent/RS50764B/sr unknown
- 2005-04-19 AT AT05740221T patent/ATE424210T1/de active
- 2005-04-19 SI SI200530673T patent/SI1729777T1/sl unknown
- 2005-04-19 MX MXPA06011830A patent/MXPA06011830A/es not_active IP Right Cessation
- 2005-04-19 WO PCT/EP2005/051714 patent/WO2005102352A1/en active Application Filing
- 2005-04-19 CN CN201010174000A patent/CN101824035A/zh active Pending
- 2005-04-19 CN CN2005800116628A patent/CN1942191B/zh not_active Expired - Fee Related
- 2005-04-19 BR BRPI0509953-6A patent/BRPI0509953A/pt not_active IP Right Cessation
- 2005-04-19 PL PL05740221T patent/PL1729777T3/pl unknown
- 2005-04-19 DE DE602005013066T patent/DE602005013066D1/de active Active
- 2005-04-19 DK DK05740221T patent/DK1729777T3/da active
- 2005-04-19 EP EP05740221A patent/EP1729777B1/en active Active
- 2005-04-20 PE PE2005000439A patent/PE20060400A1/es not_active Application Discontinuation
- 2005-04-20 AR ARP050101549A patent/AR049028A1/es unknown
-
2006
- 2006-09-20 IL IL178201A patent/IL178201A/en not_active IP Right Cessation
- 2006-10-05 ZA ZA200608305A patent/ZA200608305B/xx unknown
- 2006-10-19 EC EC2006006938A patent/ECSP066938A/es unknown
- 2006-11-03 NO NO20065077A patent/NO20065077L/no not_active Application Discontinuation
- 2006-11-21 LV LVP-06-130A patent/LV13556B/lv unknown
-
2009
- 2009-03-31 HR HR20090190T patent/HRP20090190T1/xx unknown
- 2009-05-05 CY CY20091100481T patent/CY1109018T1/el unknown
-
2013
- 2013-03-08 JP JP2013046645A patent/JP2013136626A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049028A1 (es) | Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion | |
CL2009000903A1 (es) | Composiciones farmacéuticas que comprenden un núcleo que contiene una droga débilmente básica seleccionada de derivados de butirofenona, una capa de amortiguador de ph alcalino y un recubrimiento de liberación controlada, método para preparar dichas composiciones y formas de dosificación farmacéutica que las incluyen. | |
ES2581331T3 (es) | Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática | |
NO20081592L (no) | Dipeptidylpeptidaseinhibitorer for behandling av diabetes | |
CL2008002255A1 (es) | Compuesto 3-({4-(2,2-difluoroetil)-3-(1h-pirrolo [2,3-b] piridin-5-il)-1h-pirazol-4-il] pirimidin-2-il}amino)propanonitrilo, inhibidor de raf; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del crecimiento celular anormal o cualquier enfermedad o afeccion mediada por raf. | |
ECSP056020A (es) | Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion | |
UY29633A1 (es) | Derivados de oxindol | |
RS52743B (en) | (2S, 3R) -N- (2 - ((3-PYRIDINYL) METHYL) -1-AZABICYCLO [2.2.2] OCT-3-IL) BENZOFURAN-2-CARBOXAMID, NEW FORMS OF SALTS AND PROCEDURES FOR THEIR USE | |
HN2006007884A (es) | Derivados de oxiindol | |
NO20093146L (no) | Amino-pyridinderivater som S1P1/EDG1-reseptoragonister | |
CL2007003100A1 (es) | Compuestos derivados de pirimidina, inhibidores de cisteina proteasa; procesos de preparacion; sales de los compuestos; composicion farmaceutica; y uso para el tratamiento de la malaria. | |
CR6436A (es) | Inhibidores de la receptacion de monoaminas para el tratamiento de trastornos del snc | |
AR063538A1 (es) | Tratamiento de la enfermedad de parkinson | |
CL2008002809A1 (es) | Compuestos derivados de cianoisoquinolina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una adiccion a las drogas, en el tratamiento de un trastorno neurodegenerativo, como alzheimer, parkinson, demencia, entre otros. | |
AR082493A1 (es) | Formulaciones a base de nalbufina, y sus utilizaciones | |
CL2018001092A1 (es) | Composiciones de pirimidina, composiciones ultrapuras y sales de las mismas, métodos su elaboración y métodos para sus uso en el tratamiento de enfermedades y afecciones mediadas por el receptor histamínico. | |
AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
AR058047A1 (es) | Administracion de inhibidores de dipeptidil peptidasa | |
AR058105A1 (es) | Derivados de piperazina utiles como agonistas de ccr5 | |
UY34647A (es) | Composiciones farmacéuticas | |
BRPI0819914A2 (pt) | método para tratar uma doença, uso de um composto e seus sais farmaceuticamente aceitáveis, e, composto. | |
CY1118132T1 (el) | ΣΤΕΡΕΕΣ ΜΟΡΦΕΣ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ (1R,4R)-6'-ΦΘΟΡΟ-Ν,Ν-ΔΙΜΕΘΥΛ-4-ΦΑΙΝΥΛ-4',9'-ΔΙΥΔΡΟ-3´H-ΣΠΕΙΡΟ-[ΚΥΚΛΟΕΞΑΝΟ-1,1'-ΠΥΡΑΝΟ[3,4,b]ΙΝΔΟΛ]-4-ΑΜΙΝΗΣ | |
TW200507850A (en) | Pharmaceutical composition | |
RU2006111610A (ru) | Способ лечения эректильной дисфункции у мужчин | |
AR074981A1 (es) | Derivados de etan-amina, composiciones farmaceuticas y usos para el tratamiento de depresion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |